Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway
Yıl: 2018 Cilt: 5 Sayı: 2 Sayfa Aralığı: 89 - 95 Metin Dili: İngilizce DOI: 10.14744/nci.2017.55798 İndeks Tarihi: 25-02-2020
Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway
Öz: OBJECTIVE: Diphtheria toxin (DTx) is a well-characterized bacterial toxin. However, the endocytic pathway of the mutantof DTx, CRM197, which is used as an immunological adjuvant, has not yet been fully explained. The aim of this study was toinvestigate the intracellular trafficking of CRM197-loaded endosomes.METHODS: Human umbilical vein endothelial cells (HUVECs) were used in a cell culture. The effective incubation time wasdetermined by transmission electron microscopy in toxin-treated cells. Density gradient centrifugation and ADP-ribosylationassay were used to isolate and detect toxin-loaded endosomal fractions. Endosomal fractions from CRM197-treated cells wereelicited after 15 minutes of incubation and the presence of fragment A was demonstrated using Western blot. Immunofluorescencemicroscopy was used to identify endosomes in CRM197-treated endothelial cells.RESULTS: DTx-loaded endosomes were detected as enlarged vesicles in the perinuclear area with 15 minutes of toxin treatment.DTx-loaded endosomal fractions were determined by ADP-ribosyltransferase activity test and Western blot analysis.Enzymatic activity of the toxin-loaded endosomal fraction increased by 20% in actin cytoskeletal-damaged cells treated withcytochalasin D. The steps for the toxin treatment of HUVECs with DTx and obtaining endosomal fractions were repeated forCRM197. In the CRM197-loaded endosomal fraction, actin and Hsp90 were identified in addition to fragment A. Fluorescentimages revealed that CRM197-loaded endosomes were co-localized with actin filaments and that Rab11, which signals thereturn to the plasma membrane, was more prominent than Rab7, the lysosomal pathway indicator.CONCLUSION: These results suggest that CRM197-loaded endosomes participate in the recycling pathway.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Varol B, Özerman Edis B, Bektaş M. Toxin Structure, Delivery and Action. In: Burkovski A, editor. Corynebacterium diphtheriae and Related Toxigenic Species. Dordrecht: Springer Netherlands; 2014. p. 83–94.
- Uchida T, Pappenheimer AM Jr, Greany R. Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. J Biol Chem 1973;248:3838–44.
- Shinefield HR. Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use. Vaccine 2010;28:4335–9.
- Giannini G, Rappuoli R, Ratti G. The amino-acid sequence of two nontoxic mutants of diphtheria toxin: CRM45 and CRM197. Nucleic Acids Res 1984;12:4063–9.
- Van Ness BG, Howard JB, Bodley JW. ADP-ribosylation of elongation factor 2 by diphtheria toxin. NMR spectra and proposed structures of ribosyl-diphthamide and its hydrolysis products. J Biol Chem 1980;255:10710–6.
- Naglich JG, Metherall JE, Russell DW, Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 1992;69:1051–61.
- Lemichez E, Bomsel M, Devilliers G, vanderSpek J, Murphy JR, Lukianov EV, et al. Membrane translocation of diphtheria toxin fragment A exploits early to late endosome trafficking machinery. Mol Microbiol 1997;23:445– 57.
- Bektaş M, Hacıosmanoğlu E, Ozerman B, Varol B, Nurten R, Bermek E. On diphtheria toxin fragment A release into the cytosol--cytochalasin D effect and involvement of actin filaments and eukaryotic elongation factor 2. Int J Biochem Cell Biol 2011;43:1365–72.
- Bektaş M, Varol B, Nurten R, Bermek E. Interaction of diphtheria toxin (fragment A) with actin. Cell Biochem Funct 2009;27:430–9.
- Varol B, Bektaş M, Nurten R, Bermek E. The cytotoxic effect of diphtheria toxin on the actin cytoskeleton. Cell Mol Biol Lett 2012;17:49–61.
- Unlü A, Bektaş M, Sener S, Nurten R. The interaction between actin and FA fragment of diphtheria toxin. Mol Biol Rep 2013;40:3135–45.
- Özerman Edis B, Varol B, Hacıosmanoğlu E, Ünlü A, Bektaş M. Crossreacting material 197 (CRM197) affects actin cytoskeleton of endothelial cells. Gen Physiol Biophys 2017;36:383–9.
- Scita G, Di Fiore PP. The endocytic matrix. Nature 2010;463:464–73.
- Oh KJ, Senzel L, Collier RJ, Finkelstein A. Translocation of the catalytic domain of diphtheria toxin across planar phospholipid bilayers by its own T domain. Proc Natl Acad Sci U S A 1999;96:8467–70.
- Tjelle TE, Brech A, Juvet LK, Griffiths G, Berg T. Isolation and characterization of early endosomes, late endosomes and terminal lysosomes: their role in protein degradation. J Cell Sci 1996;109:2905–14.
- Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–5.
- Morris RE, Gerstein AS, Bonventre PF, Saelinger CB. Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun 1985;50:721–7.
- Ratts R, Zeng H, Berg EA, Blue C, McComb ME, Costello CE, et al. The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol 2003;160:1139–50.
- Rousseau S, Houle F, Kotanides H, Witte L, Waltenberger J, Landry J, et al. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem 2000;275:10661–72.
- Ramel D, Wang X, Laflamme C, Montell DJ, Emery G. Rab11 regulates cell-cell communication during collective cell movements. Nat Cell Biol 2013;15:317–24.
- Antignani A, Youle RJ. Endosome fusion induced by diphtheria toxin translocation domain. Proc Natl Acad Sci U S A 2008;105:8020–5.
- Gaillard PJ, de Boer AG. A novel opportunity for targeted drug delivery to the brain. J Control Release 2006;116:e60–2.
- Tosi G, Vilella A, Veratti P, Belletti D, Pederzoli F, Ruozi B, et al. Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments. Mol Pharm 2015;12:3672–84.
| APA | ÖZERMAN EDİS B, HACIOSMANOĞLU E, VAROL B, BEKTAŞ M (2018). Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. , 89 - 95. 10.14744/nci.2017.55798 |
| Chicago | ÖZERMAN EDİS BİLGE,HACIOSMANOĞLU Ebru,VAROL BAŞAK,BEKTAŞ MUHAMMET Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. (2018): 89 - 95. 10.14744/nci.2017.55798 |
| MLA | ÖZERMAN EDİS BİLGE,HACIOSMANOĞLU Ebru,VAROL BAŞAK,BEKTAŞ MUHAMMET Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. , 2018, ss.89 - 95. 10.14744/nci.2017.55798 |
| AMA | ÖZERMAN EDİS B,HACIOSMANOĞLU E,VAROL B,BEKTAŞ M Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. . 2018; 89 - 95. 10.14744/nci.2017.55798 |
| Vancouver | ÖZERMAN EDİS B,HACIOSMANOĞLU E,VAROL B,BEKTAŞ M Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. . 2018; 89 - 95. 10.14744/nci.2017.55798 |
| IEEE | ÖZERMAN EDİS B,HACIOSMANOĞLU E,VAROL B,BEKTAŞ M "Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway." , ss.89 - 95, 2018. 10.14744/nci.2017.55798 |
| ISNAD | ÖZERMAN EDİS, BİLGE vd. "Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway". (2018), 89-95. https://doi.org/10.14744/nci.2017.55798 |
| APA | ÖZERMAN EDİS B, HACIOSMANOĞLU E, VAROL B, BEKTAŞ M (2018). Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. İstanbul Kuzey Klinikleri, 5(2), 89 - 95. 10.14744/nci.2017.55798 |
| Chicago | ÖZERMAN EDİS BİLGE,HACIOSMANOĞLU Ebru,VAROL BAŞAK,BEKTAŞ MUHAMMET Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. İstanbul Kuzey Klinikleri 5, no.2 (2018): 89 - 95. 10.14744/nci.2017.55798 |
| MLA | ÖZERMAN EDİS BİLGE,HACIOSMANOĞLU Ebru,VAROL BAŞAK,BEKTAŞ MUHAMMET Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. İstanbul Kuzey Klinikleri, vol.5, no.2, 2018, ss.89 - 95. 10.14744/nci.2017.55798 |
| AMA | ÖZERMAN EDİS B,HACIOSMANOĞLU E,VAROL B,BEKTAŞ M Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. İstanbul Kuzey Klinikleri. 2018; 5(2): 89 - 95. 10.14744/nci.2017.55798 |
| Vancouver | ÖZERMAN EDİS B,HACIOSMANOĞLU E,VAROL B,BEKTAŞ M Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway. İstanbul Kuzey Klinikleri. 2018; 5(2): 89 - 95. 10.14744/nci.2017.55798 |
| IEEE | ÖZERMAN EDİS B,HACIOSMANOĞLU E,VAROL B,BEKTAŞ M "Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway." İstanbul Kuzey Klinikleri, 5, ss.89 - 95, 2018. 10.14744/nci.2017.55798 |
| ISNAD | ÖZERMAN EDİS, BİLGE vd. "Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway". İstanbul Kuzey Klinikleri 5/2 (2018), 89-95. https://doi.org/10.14744/nci.2017.55798 |
